12.5% Isixazululo se-Amitraz
.png)
.png)
.png)
.png)
Ukwakheka
I-ml ngayinye iqukethe i-Amitraz 125 mg
Izinkomba
Isixazululo se-Amitraz esingu-12.5%.eyenzelwe ukuvikela kanye nokulawula ukuhlasela kwe-ectoparasitic njengoMikhaza, izimbuzane ze-Mange, izintwala kanye nezinkomo eNkomo, Ikamela, Izimvu, Izimbuzi kanye nezingulube.Isixazululo se-Amitraz singabulala imikhaza, izimbuzane zohlobo lwe-mange nezintwala kuhlanganise nezinhlobo ezimelana ne-organochlorines, ama-organophosphates nama-synthetic pyrethroids.
Contraindications
Lo mkhiqizo awunconywa ukuthi usetshenziswe kuhlobo lwezinja zeHhashi, Ikati ne-Chihuahua.
Umthamo kanye Nokuphatha
Isixazululo se-Amitraz esingu-12.5% singasetshenziswa njengesifutho noma idiphu
i-amitraz 12.5% isixazululo samanzi emikhaza, izimbuzane (umange), izintwala kanye nama-keds
Izinkomo/Ikamela: 2.0 ml
Izimvu/Imbuzi: 4.0 ml
Izingulube: 4.0 ml
Lungiselela isifutho ngosuku lokwelashwa usebenzisa amanzi ahlanzekile.Yelapha zonke izilwane ezithelelekile nezingatheleleki eqenjini ngesikhathi esisodwa.
Amanothi
Ezimweni ezimbi kakhulu ze-mange noma izintwala ukwelashwa kwesibili kunconywa ezinsukwini ezingu-7-10 ngemva kokwelashwa kokuqala
Isikhathi Sokuhoxiswa
Inyama- usuku olu-1 lwezinkomo nezimbuzi kanye nezinsuku eziyi-7 zezingulube nobisi lwezimvu- ukusengwa oku-4 / izinsuku ezi-2
Isitoreji
Gcina esitsheni sokuqala esivalwe ngci endaweni ephephile kude nokudla.Gcina uvikelekile ekukhanyeni
I-Hebei Veyong Pharmaceutical Co., Ltd, yasungulwa ngo-2002, etholakala eShijiazhuang City, eSifundazweni saseHebei, eChina, eduze kweNhloko-dolobha yaseBeijing.Uyibhizinisi elikhulu lemithi yezilwane eqinisekiswe yi-GMP, ene-R&D, ukukhiqizwa nokudayiswa kwama-API wezilwane, amalungiselelo, okuphakelayo okuxutshwe ngaphambili nezithasiselo zokudla.NjengeSikhungo Sezobuchwepheshe Sesifundazwe, i-Veyong isungule uhlelo olusha lwe-R&D lomuthi omusha wezilwane, futhi iyibhizinisi lezobuchwepheshe elaziwa kuzwelonke elisekelwe kudokotela wezilwane, kunochwepheshe abangama-65.I-Veyong inezisekelo ezimbili zokukhiqiza: i-Shijiazhuang ne-Ordos, lapho isisekelo se-Shijiazhuang sihlanganisa indawo engu-78,706 m2, nemikhiqizo ye-API engu-13 ehlanganisa i-Ivermectin, i-Eprinomectin, i-Tiamulin Fumarate, i-Oxytetracycline hydrochloride ects, kanye ne-11, imigqa yokukhiqiza ye-powder yokulungiselela , premix, bolus, izibulala-zinambuzane nesibulala-magciwane, njll.I-Veyong ihlinzeka ngama-API, amalungiselelo angaphezu kwe-100 elebula uqobo, kanye nesevisi ye-OEM & ODM.
I-Veyong ibheka ukubaluleka okukhulu ekuphathweni kohlelo lwe-EHS(Imvelo, Impilo Nokuphepha), futhi yathola izitifiketi ze-ISO14001 ne-OHSAS18001.I-Veyong isohlwini lwamasu amabhizinisi ezimboni asafufusa esifundazweni sase-Hebei futhi ingaqinisekisa ukuhlinzekwa okuqhubekayo kwemikhiqizo.
I-Veyong yasungula uhlelo oluphelele lokuphatha ikhwalithi, yathola isitifiketi se-ISO9001, isitifiketi se-China GMP, isitifiketi se-APVMA GMP yase-Australia, isitifiketi se-Ethiopia GMP, isitifiketi se-Ivermectin CEP, futhi yaphumelela ukuhlolwa kwe-US FDA.I-Veyong inethimba elichwepheshile lokubhalisa, ukuthengisa kanye nenkonzo yezobuchwepheshe, inkampani yethu ithole ukwethenjwa nokusekelwa kumakhasimende amaningi ngekhwalithi yomkhiqizo omuhle kakhulu, ikhwalithi ephezulu yokuthengisa kwangaphambili kanye nenkonzo yangemuva kokuthengisa, ukuphathwa okungathi sína nokwesayensi.I-Veyong yenze ukubambisana kwesikhathi eside namabhizinisi amaningi emithi yezilwane aziwa emhlabeni wonke ngemikhiqizo ethunyelwa eYurophu, eNingizimu Melika, eMpumalanga Ephakathi, e-Afrika, e-Asia, njll. emazweni nasezifundeni ezingaphezu kuka-60.
